olodaterol (Striverdi Respimat)

Indications

• chronic obstructive pulmonary disease
  • chronic bronchitis
  • pulmonary emphysema

Contraindications

• acute COPD exacerbation
• asthma exacerbation
• acute bronchospasm

Dosage

• inhalation spray as a once-daily

Adverse effects

• paradoxical bronchospasm
• nasopharyngitis
• upper respiratory tract infection
• bronchitis
• cough
• urinary tract infection
• dizziness
• rash
• diarrhea
• back pain
• arthralgia
• boxed warning highlighting:
  • increased risk for asthma-related death

• drug adverse effects of adrenergic receptor agonists
• drug adverse effects of beta-adrenergic receptor agonists
• drug adverse effects of long-acting beta-adrenergic receptor agonists
• drug adverse effects of sympathomimetic(s)

Mechanism of action

• long-acting beta-adrenergic agonist

More general terms

• long-acting beta adrenergic receptor agonist (LABA)
• inhalation agent (inhalant)

Component of

• olodaterol/tiotropium (Stiolto Respimat)